Novo Holdings A/S Portfolio Stock Holdings

Novo Holdings A/S disclosed 22 stock positions valued at approximately $1.2 billion in its latest SEC 13F filing. The largest holdings include EDGEWISE THERAPEUTICS INC, BROOKFIELD CORP, and ASML HOLDING N V. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.

Report Period
March 31, 2026
No. of Stocks
22
Portfolio Value
$1.2B
Holdings by Sector
Novo Holdings A/S Portfolio Holdings in Q1 2026

18 holdings in the latest reporting period.

Page 1 of 1
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
EDGEWISE THERAPEUTICS INCEWTXHealthcare13.65%5,350,000--$168,525,000
BROOKFIELD CORPBNFinancial Services11.46%3,496,245--$141,493,035
ASML HOLDING N VASMLOther10.16%94,946-19,000-16.67%$125,407,525
MIRUM PHARMACEUTICALS INCMIRMHealthcare9.92%1,325,000+60,972+4.82%$122,403,500
SALESFORCE INCCRMTechnology5.95%393,187+63,000+19.08%$73,396,217
CRINETICS PHARMACEUTICALS INCRNXHealthcare4.56%1,550,000-75,000-4.62%$56,296,000
ENLIVEN THERAPEUTICS INCELVNHealthcare4.07%1,280,000-200,000-13.51%$50,176,000
VAXCYTE INCPCVXHealthcare4.05%860,000-56,160-6.13%$49,974,600
PHARVARIS N VPHVSOther4.01%1,750,000--$49,437,500
ARRIVENT BIOPHARMA INCAVBPHealthcare3.63%1,942,142--$44,805,216
VIRIDIAN THERAPEUTICS INCVRDNHealthcare3.17%2,000,000-380,000-15.97%$39,120,000
CELLDEX THERAPEUTICS INC NEWCLDXHealthcare3.08%1,200,000--$38,064,000
APOGEE THERAPEUTICS INCAPGEHealthcare3.07%450,000-120,000-21.05%$37,876,500
BIOMARIN PHARMACEUTICAL INCBMRNHealthcare3.02%660,000--$37,283,400
4D MOLECULAR THERAPEUTICS INFDMTHealthcare2.75%3,650,737--$33,988,361
ALIBABA GROUP HLDG LTDBABAConsumer Cyclical2.62%257,327--$32,284,245
XENON PHARMACEUTICALS INCXENEHealthcare2.29%485,438+485,438+100.00%$28,228,220
MARQETA INCMQTechnology0.15%441,558--$1,801,557